Entry Detail



General Information

Database ID:exR0083822
RNA Name:TUBA1A
RNA Type:mRNA
Chromosome:chr12
Starnd:-
Coordinate:
Start Site(bp):49184795End Site(bp):49189080
External Links:ENSG00000167552



Disease Information

Disease Name:Fragile X Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D005600
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fragile X Syndromes//Syndrome, Fragile X//Syndromes, Fragile X//Marker X Syndrome//Marker X Syndromes//Syndrome, Marker X//Syndromes, Marker X//Mental Retardation, X-Linked, Associated With Marxq28//X-Linked Mental Retardation and Macroorchidism//X Linked Mental Retardation and Macroorchidism//Fragile X Mental Retardation Syndrome//Martin-Bell Syndrome//Martin Bell Syndrome//Syndrome, Martin-Bell//Fra(X) Syndrome//FRAXE Syndrome//FRAXE Syndromes//Syndrome, FRAXE//Syndromes, FRAXE//Mental Retardation, X-Linked, Associated With Fragile Site Fraxe//Fragile X-F Mental Retardation Syndrome//Mar (X) Syndrome//FRAXA Syndrome//FRAXA Syndromes//Syndrome, FRAXA//Syndromes, FRAXA



Expression Detail

GEO ID:GSE83556
Description:Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions
Experimental Design:Disease vs Control
Case Disease Type:Fragile X Syndrome
Case Disease SubType:NA
Case Sample:Fragile X Syndrome
Control Sample:Normal
Number of Case:22
Number of Control:18
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC124312.1
chr15
24955034
25000276
+
ACSS2
chr20
34872146
34927962
+
ADA2
chr22
17178790
17258235
-
AC120057.2
chr17
7240427
7244635
-
AHCY
chr20
34280268
34311802
-
AC093525.2
chr16
2496032
2520218
+
ADORA2A
chr22
24417879
24442357
+
AC005832.4
chr12
4604944
4662643
+
AC048338.1
chr12
122207779
122266423
-
AIF1
chr6
31615217
31617021
+
ABHD4
chr14
22598237
22613215
+
ALDH3A2
chr17
19648136
19685760
+
ACTB
chr7
5527148
5563784
-
AFDN
chr6
167826922
167972023
+
AC092073.1
chr19
34396315
34409364
+
AC092143.1
chr16
89919165
89936092
+
ALDOA
chr16
30064164
30070457
+
AAR2
chr20
36236459
36270918
+
ACTR2
chr2
65227753
65271253
+
ABCF1
chr6
30571393
30597179
+
AC245033.1
chr15
82536788
82573194
-
AC010422.3
chr19
12643831
12648397
-
ADM
chr11
10305073
10307397
+
ACBD5
chr10
27195214
27242130
-
ABCA7
chr19
1039997
1065572
+
AKAP17A
chrX
1591604
1602520
+
ACTR3
chr2
113890063
113962596
+
ACTG1
chr17
81509971
81523847
-
AGRN
chr1
1020120
1056118
+
AC005943.1
chr19
1578339
1605445
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-367-3p
chr4
112647877
112647898
-
hsa-miR-198
chr3
120395703
120395724
-
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC002116.1
chr19
36008638
36014235
-
AC016876.2
chr17
7581964
7584086
-
AC020928.1
chr19
36773112
36777078
+
AC023509.1
chr12
53441741
53467528
+
AC026362.1
chr12
122975320
122982907
+
AC106864.1
chr4
112693047
112706810
-
AC132217.1
chr11
2129121
2129964
-
AC133644.3
chr2
87455476
87767359
+
AD000090.1
chr19
35557956
35581954
+
AF106564.1
chr8
24912165
24914717
-
AL021707.2
chr22
38667585
38681847
-
AL049795.2
chr1
32170733
32176568
+
Display:



Experiment Detail

GEO ID:GSE83556
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:RNA was extracted from 5-15 mL amniotic fluid supernatant (centrifugation at 350g, 4C, 10, min).
RNA Extract protocol:All samples were processed using the Qiagen Circulating Nucleic Acid kit with an on-column DNase digestion step to remove genomic DNA. The RNA was then purified and concentrated with the RNeasy MinElute Clean up kit and eluted in RNasefree water.
RNA library preparation protocol:RNA was converted to cDNA and amplified using the Ovation Pico WTA kit V2 and then purified with the QIAquick PCR Purification kit. Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA)Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA